New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...
Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...
Women of childbearing age who had both ovaries removed, in a procedure called bilateral oophorectomy, were more likely to develop heart failure later in life, according to a study being presented at ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
Amidst global market turbulence, Asian markets have shown resilience, with Japan's stock indices experiencing modest gains and China's markets buoyed by stimulus hopes. In such an environment, ...
Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.
AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...
A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...
Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE: CTEV), previously MultiPlan, ...
On Tuesday, Merck & Co (NYSE: MRK) Inc. emerged victorious in a significant legal dispute concerning its Gardasil vaccine, which is designed to prevent cervical and other serious cancers. U.S.